$243 Million is the total value of Tamarack Advisers, LP's 48 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 77.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| THC | Buy | TENET HEALTHCARE CORPequity | $16,338,000 | +227.9% | 200,000 | +166.7% | 6.72% | +327.1% |
| PCRX | Sell | PACIRA BIOSCIENCES INCequity | $14,441,000 | -31.2% | 240,000 | -36.0% | 5.94% | -10.5% |
| MDT | Sell | MEDTRONIC PLCequity | $12,931,000 | -48.4% | 125,000 | -37.5% | 5.32% | -32.8% |
| BVS | Buy | BIOVENTUS INC - Aequity | $12,679,000 | +86.5% | 875,000 | +82.3% | 5.21% | +142.9% |
| SIBN | Buy | SI-BONE INCequity | $12,216,000 | +42.6% | 550,000 | +37.5% | 5.02% | +85.7% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INCequity | $11,925,000 | -53.1% | 4,500,000 | -35.7% | 4.90% | -38.9% |
| LNTH | Sell | LANTHEUS HOLDINGS INCequity | $10,256,000 | +2.4% | 355,000 | -9.0% | 4.22% | +33.4% |
| ANGO | Sell | ANGIODYNAMICS INCequity | $9,515,000 | +4.8% | 345,000 | -1.4% | 3.91% | +36.4% |
| TPB | Sell | TURNING POINT BRANDS INCequity | $9,445,000 | -28.1% | 250,000 | -9.1% | 3.88% | -6.3% |
| HUM | New | HUMANA INCequity | $9,277,000 | – | 20,000 | +100.0% | 3.81% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INCequity | $7,952,000 | – | 90,000 | +100.0% | 3.27% | – |
| STRM | STREAMLINE HEALTH SOLUTIONSequity | $7,347,000 | -14.9% | 4,930,882 | 0.0% | 3.02% | +10.9% | |
| ATRC | Sell | ATRICURE INCequity | $6,953,000 | -14.6% | 100,000 | -14.5% | 2.86% | +11.3% |
| CERS | Buy | CERUS CORPequity | $6,810,000 | +1390.2% | 1,000,000 | +1233.3% | 2.80% | +1844.4% |
| VTRS | New | VIATRIS INCequity | $6,765,000 | – | 500,000 | +100.0% | 2.78% | – |
| VRAY | Sell | VIEWRAY INCequity | $6,612,000 | -42.7% | 1,200,000 | -25.0% | 2.72% | -25.4% |
| ELY | Sell | CALLAWAY GOLF COMPANYequity | $5,488,000 | -55.9% | 200,000 | -55.6% | 2.26% | -42.5% |
| MRK | New | MERCK & CO. INC.equity | $5,365,000 | – | 70,000 | +100.0% | 2.21% | – |
| MCK | New | MCKESSON CORPequity | $4,971,000 | – | 20,000 | +100.0% | 2.04% | – |
| SMG | New | SCOTTS MIRACLE-GRO COequity | $4,830,000 | – | 30,000 | +100.0% | 1.99% | – |
| BAX | New | BAXTER INTERNATIONAL INCequity | $4,292,000 | – | 50,000 | +100.0% | 1.76% | – |
| CVS | New | CVS HEALTH CORPequity | $4,126,000 | – | 40,000 | +100.0% | 1.70% | – |
| PLXS | Buy | PLEXUS CORPequity | $4,027,000 | +12.6% | 42,000 | +5.0% | 1.66% | +46.7% |
| ISEE | Sell | IVERIC BIO INCequity | $3,762,000 | -7.3% | 225,000 | -10.0% | 1.55% | +20.7% |
| MDRX | Sell | ALLSCRIPTS HEALTHCARE SOLUTIequity | $3,690,000 | -52.0% | 200,000 | -65.2% | 1.52% | -37.5% |
| RDNT | Sell | RADNET INCequity | $3,312,000 | -40.5% | 110,000 | -42.1% | 1.36% | -22.5% |
| UTHR | Sell | UNITED THERAPEUTICS CORPequity | $3,241,000 | -73.0% | 15,000 | -76.9% | 1.33% | -64.8% |
| JAZZ | New | JAZZ PHARMACEUTICALS PLCequity | $3,185,000 | – | 25,000 | +100.0% | 1.31% | – |
| INMD | New | INMODE LTDequity | $3,176,000 | – | 45,000 | +100.0% | 1.31% | – |
| PHR | PHREESIA INCequity | $3,125,000 | -32.5% | 75,000 | 0.0% | 1.28% | -12.0% | |
| AHCO | Sell | ADAPTHEALTH CORPequity | $3,058,000 | -25.0% | 125,000 | -28.6% | 1.26% | -2.3% |
| PDCO | Sell | PATTERSON COS INCequity | $2,935,000 | -80.3% | 100,000 | -79.8% | 1.21% | -74.4% |
| HSIC | Sell | HENRY SCHEIN INCequity | $2,869,000 | -90.6% | 37,000 | -90.8% | 1.18% | -87.7% |
| XBI | New | SPDR S&P BIOTECH ETFexchange traded fund | $2,799,000 | – | 25,000 | +100.0% | 1.15% | – |
| TCNNF | New | TRULIEVE CANNABIS CORPequity | $2,211,000 | – | 85,000 | +100.0% | 0.91% | – |
| ITGR | Sell | INTEGER HOLDINGS CORPequity | $2,140,000 | -80.8% | 25,000 | -80.0% | 0.88% | -75.0% |
| CI | New | CIGNA CORPequity | $1,837,000 | – | 8,000 | +100.0% | 0.76% | – |
| SOMALOGIC INCequity | $1,746,000 | -6.1% | 150,000 | 0.0% | 0.72% | +22.3% | ||
| GTBIF | Buy | GREEN THUMB INDUSTRIES INCequity | $1,662,000 | +497.8% | 75,000 | +650.0% | 0.68% | +676.1% |
| New | VERANO HOLDINGS CORPequity | $944,000 | – | 75,000 | +100.0% | 0.39% | – | |
| Sell | TERRASCEND CORPequity | $917,000 | -47.9% | 150,000 | -40.0% | 0.38% | -32.2% | |
| New | TDOC US 01/21/22 P115put | $584,000 | – | 250 | +100.0% | 0.24% | – | |
| UNH | New | UNITEDHEALTH GROUP INCequity | $502,000 | – | 1,000 | +100.0% | 0.21% | – |
| New | IWM US 02/18/22 P215put | $425,000 | – | 1,000 | +100.0% | 0.18% | – | |
| PRGO | Sell | PERRIGO CO PLCequity | $389,000 | -96.7% | 10,000 | -96.0% | 0.16% | -95.7% |
| CM LIFE SCIENCES II -CW27warrant | $67,000 | -2.9% | 20,000 | 0.0% | 0.03% | +27.3% | ||
| New | VTRS US 01/21/22 C15call | $60,000 | – | 10,000 | +100.0% | 0.02% | – | |
| New | RIGL US 01/21/22 C10call | $14,000 | – | 5,705 | +100.0% | 0.01% | – | |
| BMRN | Exit | BMRN US 10/15/21 C85call | $0 | – | -1,500 | -100.0% | -0.01% | – |
| MSACW | Exit | MEDICUS SCIENCES ACQ -CW27warrant | $0 | – | -66,665 | -100.0% | -0.02% | – |
| RIGL | Exit | RIGL US 01/21/22 C10call | $0 | – | -5,000 | -100.0% | -0.03% | – |
| NUVA | Exit | NUVA US 11/19/21 P65put | $0 | – | -231 | -100.0% | -0.04% | – |
| PFE | Exit | PFE US 11/19/21 C43call | $0 | – | -1,000 | -100.0% | -0.05% | – |
| VTRS | Exit | VTRS US 01/21/22 C15call | $0 | – | -5,000 | -100.0% | -0.08% | – |
| HSIC | Exit | HSIC US 11/19/21 C80call | $0 | – | -1,500 | -100.0% | -0.13% | – |
| HOLX | Exit | HOLX US 12/17/21 C75call | $0 | – | -1,000 | -100.0% | -0.13% | – |
| ARKG | Exit | ARKG US 10/15/21 P85put | $0 | – | -750 | -100.0% | -0.23% | – |
| NVST | Exit | ENVISTA HOLDINGS CORPequity | $0 | – | -45,000 | -100.0% | -0.59% | – |
| SPY | Exit | SPY US 10/01/21 P440put | $0 | – | -2,000 | -100.0% | -0.65% | – |
| Exit | DERMTECH INCequity | $0 | – | -85,000 | -100.0% | -0.86% | – | |
| TALK | Exit | TALKSPACE INCequity | $0 | – | -800,000 | -100.0% | -0.92% | – |
| STE | Exit | STERIS PLCequity | $0 | – | -36,000 | -100.0% | -2.32% | – |
| ICUI | Exit | ICU MEDICAL INCequity | $0 | – | -35,000 | -100.0% | -2.58% | – |
| MSON | Exit | MISONIX INCequity | $0 | – | -400,000 | -100.0% | -3.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERADIGM ORD | 32 | Q3 2023 | 13.9% |
| STREAMLINE HEALTH SOLUTIONS ORD | 30 | Q3 2023 | 4.0% |
| ATRICURE ORD | 29 | Q3 2023 | 7.6% |
| PACIRA PHARMACEUTICALS INC | 27 | Q1 2023 | 12.1% |
| LANTHEUS HOLDINGS ORD | 25 | Q4 2022 | 9.6% |
| MEDTRONIC PLC | 21 | Q1 2022 | 12.7% |
| RIGEL PHARMACEUTICALS ORD | 21 | Q2 2023 | 8.0% |
| BIO RAD LABORATORIES CL A ORD | 19 | Q2 2023 | 10.0% |
| HOLOGIC INC | 17 | Q1 2022 | 6.5% |
| SPY US 10/21/16 P210 | 17 | Q3 2023 | 41.5% |
View Tamarack Advisers, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTIONS INC. | June 22, 2023 | 5,514,515 | 9.4% |
| IVERIC bio, Inc. | February 16, 2021 | 850,000 | 0.1% |
| Correvio Pharma Corp. | February 14, 2020 | 2,500,000 | 4.9% |
| OBALON THERAPEUTICS INC | February 14, 2020 | ? | ? |
| Correvio Pharma Corp. | February 15, 2019 | ? | ? |
| Corium International, Inc. | February 15, 2017 | 737,242 | 3.3% |
| ENDOLOGIX INC /DE/Sold out | February 15, 2017 | 0 | 0.0% |
| Imprivata IncSold out | February 15, 2017 | 0 | 0.0% |
View Tamarack Advisers, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-08-10 |
| SC 13D/A | 2023-06-22 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-01 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-11 |
View Tamarack Advisers, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.